Literature DB >> 11834685

Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine.

Tatsuo Tomita1, Qiong Zhao.   

Abstract

A 36-year-old woman (height, 157 cm; weight, 117 kg; body mass index, 47.5) received fenfluramine and phentermine (fen-phen) for 7 months, and pulmonary hypertension subsequently developed. Her pulmonary arterial pressure was 56 mm Hg, and echocardiography showed right ventricular dilatation and hypokinesia. Cardiopulmonary arrest developed during right-heart catheterization, and she died 3 days later. At autopsy, right ventricular dilatation with fibroproliferative tricuspid valve was identified. The pulmonary arteries, including the main arteries and elastic arteries to the arterioles, revealed fibroproliferative plaque; the latter was more severe and more prominent in the upper lobes than in the lower lobes. Combined cardiac valvular disease and pulmonary hypertension appear to occur frequently in patients receiving fen-phen, and more autopsy cases of patients with a history of fen-phen usage are warranted to document the frequency of combined cardiac valvular disease and pulmonary hypertension in the United States.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834685     DOI: 10.1378/chest.121.2.649

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Pulmonary hypertension, hyperthyroidism, and fenfluramine: a case report and review.

Authors:  Ying Ying Leung; Kam Shing Tang; Chiu Chi Tsang; Chi Kin Chan; Kwan Keung Wong; Alex Wai-yin Yu
Journal:  MedGenMed       Date:  2006-11-08

2.  Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals.

Authors:  Charles F Dahl; Marvin R Allen; Paul M Urie; Paul N Hopkins
Journal:  BMC Med       Date:  2008-11-06       Impact factor: 8.775

3.  Spontaneous pneumomediastinum.

Authors:  Michael M Mohseni
Journal:  Int J Emerg Med       Date:  2008-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.